19.15
前日終値:
$18.54
開ける:
$18.52
24時間の取引高:
3.48M
Relative Volume:
1.30
時価総額:
$2.42B
収益:
$631.73M
当期純損益:
$-239.78M
株価収益率:
-9.4802
EPS:
-2.02
ネットキャッシュフロー:
$-33.45M
1週間 パフォーマンス:
-0.67%
1か月 パフォーマンス:
-6.40%
6か月 パフォーマンス:
+55.82%
1年 パフォーマンス:
+58.79%
10 X Genomics Inc Stock (TXG) Company Profile
名前
10 X Genomics Inc
セクター
電話
(925) 401-7300
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Compare TXG vs VEEV, TEM, BTSG, HQY, DOCS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
TXG
10 X Genomics Inc
|
19.15 | 2.35B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
186.99 | 30.35B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
55.88 | 10.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
39.34 | 7.17B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
78.35 | 6.77B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
27.24 | 5.08B | 550.17M | 201.35M | 232.07M | 1.00 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-12-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-11 | 開始されました | Piper Sandler | Neutral |
| 2025-02-13 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | 開始されました | Leerink Partners | Outperform |
| 2024-07-22 | アップグレード | Jefferies | Hold → Buy |
| 2024-07-18 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-10 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2024-06-27 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2024-05-01 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-12-12 | アップグレード | BofA Securities | Underperform → Neutral |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-10 | 開始されました | Barclays | Overweight |
| 2023-03-31 | 開始されました | Stephens | Overweight |
| 2023-02-02 | 開始されました | UBS | Neutral |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-08-18 | ダウングレード | Goldman | Neutral → Sell |
| 2022-07-25 | 開始されました | Canaccord Genuity | Buy |
| 2022-07-15 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-07-15 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-09-14 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-03-15 | 開始されました | William Blair | Outperform |
| 2020-12-02 | 開始されました | Goldman | Neutral |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-07-10 | 開始されました | Stifel | Buy |
| 2020-03-05 | 開始されました | Guggenheim | Buy |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-10-07 | 開始されました | BofA/Merrill | Buy |
| 2019-10-07 | 開始されました | Cowen | Outperform |
| 2019-10-07 | 開始されました | JP Morgan | Overweight |
| 2019-09-24 | 開始されました | Evercore ISI | Outperform |
すべてを表示
10 X Genomics Inc (TXG) 最新ニュース
10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch - MSN
Best Genetic Sequencing Stocks to Buy in 2026 and How to Invest in Them - The Motley Fool
10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Finviz
PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology - PR Newswire
Fundamentals Check: Can 10x Genomics Inc sustain its profitabilityBull Run & Daily Profit Focused Screening - baoquankhu1.vn
Foundations Investment Advisors LLC Takes Position in 10x Genomics $TXG - MarketBeat
10x Genomics $TXG Holdings Decreased by Federated Hermes Inc. - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Purchases New Shares in 10x Genomics $TXG - MarketBeat
AlphaQuest LLC Increases Holdings in 10x Genomics $TXG - MarketBeat
Is 10x Genomics Inc. still a buy after recent gainsPortfolio Profit Report & AI Enhanced Trading Signals - Mfd.ru
Stock Report: Will 10x Genomics Inc. outperform its industry peersJuly 2025 Rallies & Expert Approved Momentum Ideas - mfd.ru
Breaking Down 10x Genomics: 13 Analysts Share Their Views - Benzinga
10x Genomics (NASDAQ:TXG) Given New $20.00 Price Target at Leerink Partners - MarketBeat
10x Genomics, Inc. (NASDAQ:TXG) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected - simplywall.st
Volume Report: How does 10x Genomics Inc perform in inflationary periods2025 Price Action Summary & Daily Stock Trend Watchlist - baoquankhu1.vn
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - BioSpace
10x Genomics Expands Clinical Ambitions As Momentum Outruns Analyst Targets - simplywall.st
10x Genomics to Report Fourth Quarter and Full Year 2025 Financi - GuruFocus
Zacks Industry Outlook Highlights Doximity, 10x Genomics and Omnicell - Yahoo Finance
Revenue Check: What is VERX s P E ratio telling usAnalyst Upgrade & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Inscription Capital LLC Acquires 59,305 Shares of 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Trading Up 8%Still a Buy? - MarketBeat
10x Genomics Inc (TXG) Trading 6.38% Higher on Jan 20 - GuruFocus
10X Genomics stock hits 52-week high of 21.52 USD - Investing.com
Cathie Wood's Ark Unleashes Cryptic ARKmoji Teasers To Showcase Its 'Big Ideas' For 2026: Can You Take A Guess At The Hidden Meaning? - Benzinga
Sentiment Recap: Is 10x Genomics Inc a strong candidate for buy and hold2025 Momentum Check & Real-Time Buy Signal Alerts - baoquankhu1.vn
Aug Breakouts: Is United States Steel Corporation stock a good pick for beginnersQuarterly Growth Report & Capital Protection Trade Alerts - baoquankhu1.vn
Aug Ideas: Can 10x Genomics Inc stock outperform in a bear marketJuly 2025 Closing Moves & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Did 10x Genomics’ (TXG) Clinical Collaborations and CLIA Push Just Recast Its Investment Narrative? - simplywall.st
Sumitomo Mitsui Trust Group Inc. Sells 636,744 Shares of 10x Genomics $TXG - MarketBeat
Aug Weekly: Whats the fair value of AN2 Therapeutics Inc stockWeekly Investment Summary & Technical Pattern Alert System - baoquankhu1.vn
Wall Street Recap: What is INTA s revenue forecastTrade Performance Summary & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Insider Trends: Will 10x Genomics Inc outperform its industry peersJuly 2025 Review & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Weak Instrument Sales And No 2026 Outlook Could Be A Game Changer For 10x Genomics (TXG) - Yahoo Finance
10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling - BioSpace
Analysts Offer Insights on Healthcare Companies: Stryker (SYK) and 10x Genomics (TXG) - The Globe and Mail
Why 10x Genomics (TXG) Shares Are Falling Today - Finviz
10x Genomics (NASDAQ:TXG) Shares Down 8.5%What's Next? - MarketBeat
Cancer Research Institute Launches Transformative AI-Driven Immu - GuruFocus
10x Genomics partners with Dana-Farber to research cancer treatment responses - Investing.com
10x Genomics partners with Brigham & Women’s for autoimmune research - Investing.com
10x Genomics partners with Brigham & Women’s for autoimmune research By Investing.com - Investing.com Canada
10x Genomics Launches Study to Advance Research in Blood-Based D - GuruFocus
10x Genomics to Advance Research in Diagnostic Applications of T - GuruFocus
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease - PR Newswire
Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology - PR Newswire
10x Genomics (TXG) Sees Modest Q4 Growth Amid Revenue Challenges - GuruFocus
10x Genomics sees uptick in Q4 revenue despite softer FY sales (TXG:NASDAQ) - Seeking Alpha
10x Genomics (TXG) Achieves Remarkable Progress Despite Economic Challenges - GuruFocus
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results - The Malaysian Reserve
Revenues Not Telling The Story For 10x Genomics, Inc. (NASDAQ:TXG) After Shares Rise 32% - 富途牛牛
10 X Genomics Inc (TXG) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):